Abstract

BackgroundCryptococcal meningitis (CCM) is the leading cause of meningitis in people living with HIV (PLWH) in sub-Saharan Africa (SSA). The mortality and morbidity associated with CCM remain high. Combination of antifungal therapy, diligent management of intracranial pressure (IP) and the correct timing of the introduction of antiretroviral therapy (ART) minimise the risk of mortality and morbidity. The absence of spinal manometers in many healthcare centres in SSA challenges the accurate measurement of cerebrospinal fluid (CSF) pressure and its control.ObjectivesWe hypothesised that four lumbar punctures (LPs) in the first week of the diagnosis and treatment of CCM would reduce IP such that in-hospital mortality and morbidity of HIV-associated CCM (HIV/CCM) would be significantly reduced.MethodsWe conducted a retrospective study to assess whether receipt of four or more LPs in the first week of the diagnosis and treatment with combination antifungal therapy of HIV/CCM would be associated with the reduction of in-hospital mortality in adult PLWH.ResultsFrom 01 January 2016 to 31 December 2016, 116 adult patients were admitted to the Dora Nginza District Hospital in Zwide, Port Elizabeth, South Africa. After exclusion of 11 (two were younger than 18 years, two had missing hospital records and seven demised or left the hospital before 7 days of hospitalisation), 105 patients were included in the analysis. The mean age was 39.4 (standard deviation [s.d.] ± 9.7) years, 64.8% were male. All were PLWH. A total of 52.4% had defaulted ART and 25.7% were ART naïve. Forty-three patients received four or more LPs (mean = 4.58 [± 0.96]) in the first week of hospitalisation with an associated in-hospital mortality of 11.6% (n = 5/43) compared with 62 patients who received less than four LPs (mean = 2.18 [± 0.80]) with an in-hospital mortality of 29% (n = 18/62) and a relative risk of 0.80 (95% CI, 0.66–0.97), p = 0.034.ConclusionIn the current study of adult PLWH presenting to hospital with HIV/CCM, four or more LPs in the first 7 days following admission and the initiation of treatment were associated with a 17.4% reduction in absolute risk of in-hospital mortality and a 20% reduction in relative risk of in-hospital mortality. This mortality difference was noted in patients who survived and were in hospital at the time of the 7-day study census and persisted until the time of hospital discharge.

Highlights

  • Cryptococcal meningitis (CCM) is the leading cause of meningitis in people living with HIV (PLWH) in sub-Saharan Africa (SSA)

  • Cryptococcal meningitis (CCM) accounts for up to 60% of meningitis in adult persons living with HIV (PLWH) in many African countries including South Africa (SA).[1,2]

  • The availability of antiretroviral therapy (ART) has led to a decrease in HIV-associated CCM (HIV/CCM) in high-income countries,[5] the condition remains responsible for 10% – 20% of HIV-related deaths in SSA.[6]

Read more

Summary

Introduction

Cryptococcal meningitis (CCM) is the leading cause of meningitis in people living with HIV (PLWH) in sub-Saharan Africa (SSA). Cryptococcal meningitis (CCM) accounts for up to 60% of meningitis in adult persons living with HIV (PLWH) in many African countries including South Africa (SA).[1,2] Those with CD4 cell counts < 100 cells/μL are at risk.[3] Mortality is high – reaching levels of 70% in sub-Saharan Africa (SSA).[3] Altered mental state at presentation, older age, high cerebrospinal fluid (CSF) fungal burden and high peripheral white cell count predict mortality in antiretroviral therapy (ART) naïve patients.[4] the availability of ART has led to a decrease in HIV-associated CCM (HIV/CCM) in high-income countries,[5] the condition remains responsible for 10% – 20% of HIV-related deaths in SSA.[6] Notwithstanding improved access to ART, many remain outside of care or on failing treatment and at risk of opportunistic disease.[7] http://www.sajhivmed.org.za

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call